Literature DB >> 21837784

Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.

Iain J Macleod1, Belinda O'Donnell, Sikhulile Moyo, Shahin Lockman, Roger L Shapiro, Mukendi Kayembe, Erik van Widenfelt, Joseph Makhema, M Essex, Carolyn Wester.   

Abstract

Human papillomaviruses (HPV) constitute one of the most prevalent sexually transmitted infections and are the etiological agents for invasive cervical cancer, the predominant cancer among women in Botswana. However, the prevalence of HPV genotypes in Botswana has yet to be reported. One hundred thirty-nine endocervical swabs were taken at baseline from HIV-1 infected, HSV-2 seropositive women enrolled in a longitudinal cohort study designed to assess the influence of herpes simplex virus-2 (HSV-2) infection on genital tract shedding of HIV-1. Extracted DNA was evaluated for the presence of low-risk and high-risk HPV using the Roche Linear Array. Genotyping identified HPV in 95 of 139 women of which 61/95 were infected with high-risk HPV and 56/95 with low-risk HPV. The median number of genotypes was 2 (IQR: 1-4). The most prevalent HPV genotype in HIV-infected women was HPV 58. Abnormal cervical cytology was detected in 87/127 women and was associated with contemporaneous HPV infection (RR = 1.43, 95% CI: 1.05-1.93; P = 0.02). HPV prevalence was high among HIV-infected women with infection by multiple genotypes being widespread. The associations attributed to specific oncogenic HPV subtypes and cervical squamous intraepithelial lesions presented here provide critical information to inform future vaccine policy within Botswana.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21837784      PMCID: PMC3156037          DOI: 10.1002/jmv.22178

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  24 in total

1.  The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens.

Authors:  Yin Ling Woo; Isabelle Damay; Margaret Stanley; Robin Crawford; Jane Sterling
Journal:  J Virol Methods       Date:  2007-02-23       Impact factor: 2.014

2.  Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication.

Authors:  Ni Li; Silvia Franceschi; Rebecca Howell-Jones; Peter J F Snijders; Gary M Clifford
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

3.  HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda.

Authors:  Nienke J Veldhuijzen; Joseph Vyankandondera; Janneke H van de Wijgert
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

4.  Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain.

Authors:  J del Amo; C González; J Losana; P Clavo; L Muñoz; J Ballesteros; A García-Saiz; M J Belza; M Ortiz; B Menéndez; J del Romero; F Bolumar
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

5.  Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York.

Authors:  Amneris E Luque; Musaret Jabeen; Susan Messing; Christopher A Lane; Lisa M Demeter; Robert C Rose; Richard C Reichman
Journal:  J Infect Dis       Date:  2006-07-13       Impact factor: 5.226

6.  Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.

Authors:  Cecily Banura; Sven Sandin; Leen-Jan van Doorn; Wim Quint; Bernhard Kleter; Fred Wabwire-Mangen; Edward K Mbidde; Elisabete Weiderpass
Journal:  Infect Agent Cancer       Date:  2010-04-09       Impact factor: 2.965

7.  Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections.

Authors:  Karen K Smith-McCune; Stephen Shiboski; Mike Z Chirenje; Tsitsi Magure; Jennifer Tuveson; Yifei Ma; Maria Da Costa; Anna-Barbara Moscicki; Joel M Palefsky; Rudo Makunike-Mutasa; Tsungai Chipato; Ariane van der Straten; George F Sawaya
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

8.  Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia.

Authors:  V V Sahasrabuddhe; M H Mwanahamuntu; S H Vermund; W K Huh; M D Lyon; J S A Stringer; G P Parham
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

9.  Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers.

Authors:  Stanley M F Luchters; Davy Vanden Broeck; Matthew F Chersich; Annalene Nel; Wim Delva; Kishor Mandaliya; Christophe E Depuydt; Patricia Claeys; John-Paul Bogers; Marleen Temmerman
Journal:  BMC Infect Dis       Date:  2010-01-26       Impact factor: 3.090

10.  Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa.

Authors:  Cynthia Firnhaber; Hoa Van Le; Audrey Pettifor; Doreen Schulze; Pam Michelow; Ian M Sanne; David A Lewis; Anna-Lise Williamson; Bruce Allan; Sophia Williams; Allen Rinas; Simon Levin; Jennifer S Smith
Journal:  Cancer Causes Control       Date:  2009-12-01       Impact factor: 2.506

View more
  21 in total

1.  Cancer in the shadow of the AIDS epidemic in southern Africa.

Authors:  Julie Livingston
Journal:  Oncologist       Date:  2013

2.  Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Pragna Patel; Charles E Rose; Pamela Y Collins; Bernardo Nuche-Berenguer; Vikrant V Sahasrabuddhe; Emmanuel Peprah; Susan Vorkoper; Sonak D Pastakia; Dianne Rausch; Naomi S Levitt
Journal:  AIDS       Date:  2018-07-01       Impact factor: 4.177

3.  Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana.

Authors:  Doreen Ramogola-Masire; Ronny de Klerk; Barati Monare; Bakgaki Ratshaa; Harvey M Friedman; Nicola M Zetola
Journal:  J Acquir Immune Defic Syndr       Date:  2012-03-01       Impact factor: 3.731

4.  High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.

Authors:  Deepa Reddy; Joseph Njala; Penny Stocker; Alan Schooley; Martiniano Flores; Chi-Hong Tseng; Colin Pfaff; Perry Jansen; Ronald T Mitsuyasu; Risa M Hoffman
Journal:  Int J STD AIDS       Date:  2014-06-13       Impact factor: 1.359

5.  Distribution of human papillomavirus (HPV) types and anti-HPV T-cell immune responses among different racial/ethnic groups in Central Arkansas.

Authors:  Mayumi Nakagawa; Horace J Spencer; Hannah N Coleman; William W Greenfield
Journal:  J Ark Med Soc       Date:  2013-01

6.  Meta-synthesis and science mapping analysis of HIV/HPV co-infection: a global perspective with emphasis on Africa.

Authors:  Hope Onohuean; Eric O Aigbogun; Bright E Igere
Journal:  Global Health       Date:  2022-03-24       Impact factor: 4.185

7.  A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.

Authors:  Jessica L Castilho; José Eduardo Levi; Paula M Luz; Mary Catherine Cambou; Tazio Vanni; Angela de Andrade; Mônica Derrico; Valdiléa G Veloso; Beatriz Grinsztejn; Ruth K Friedman
Journal:  BMC Cancer       Date:  2015-06-23       Impact factor: 4.430

8.  Prognostic evaluation of DNA index in HIV-HPV co-infected women cervical samples attending in reference centers for HIV-AIDS in Recife.

Authors:  Albert Eduardo Silva Martins; Norma Lucena-Silva; Renan Gomes Garcia; Stefan Welkovic; Aureliana Barbosa; Maria Luiza Bezerra Menezes; Terezinha Tenório; Magda Maruza; Ricardo A A Ximenes
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

9.  Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.

Authors:  Rebecca Luckett; Neo Mogowa; Howard J Li; Adrienne Erlinger; Michele R Hacker; Katharine Esselen; Sarah Feldman; Roger Shapiro; Chelsea Morroni; Doreen Ramogola-Masire
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.661

10.  Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.

Authors:  Leabaneng Tawe; Emily MacDuffie; Mohan Narasimhamurthy; Qiao Wang; Simani Gaseitsiwe; Sikhulile Moyo; Ishmael Kasvosve; Sanghyuk S Shin; Nicola M Zetola; Giacomo M Paganotti; Surbhi Grover
Journal:  Int J Cancer       Date:  2019-08-02       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.